Bridgeway Capital Management’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
+55,100
| New | +$279K | 0.01% | 882 |
|
|
2025
Q1 | – | Sell |
-77,195
| Closed | -$670K | – | 1185 |
|
|
2024
Q4 | $670K | Sell |
77,195
-3,400
| -4% | -$29.5K | 0.02% | 756 |
|
|
2024
Q3 | $559K | Hold |
80,595
| – | – | 0.01% | 839 |
|
|
2024
Q2 | $500K | Sell |
80,595
-2,000
| -2% | -$12.4K | 0.01% | 860 |
|
|
2024
Q1 | $131K | Sell |
82,595
-50,000
| -38% | -$79K | ﹤0.01% | 1178 |
|
|
2023
Q4 | $195K | Hold |
132,595
| – | – | ﹤0.01% | 1139 |
|
|
2023
Q3 | $123K | Hold |
132,595
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q2 | $167K | Sell |
132,595
-105
| -0.1% | -$132 | ﹤0.01% | 1175 |
|
|
2023
Q1 | $182K | Hold |
132,700
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q4 | $238K | Hold |
132,700
| – | – | 0.01% | 1046 |
|
|
2022
Q3 | $417K | Hold |
132,700
| – | – | 0.01% | 939 |
|
|
2022
Q2 | $430K | Buy |
132,700
+57,700
| +77% | +$187K | 0.01% | 913 |
|
|
2022
Q1 | $382K | Buy |
+75,000
| New | +$382K | 0.01% | 1010 |
|